Supply-chain and competitive pressures prompt Goldman Sachs to maintain a Neutral rating on York Space Systems and cut its price target to $14

Overview

This report evaluates York Space Systems' 2Q26 results, full-year guidance revision, orders and cash flow position, and competitive environment. Goldman Sachs believes the company continues to face substantial defense demand and growing commercial program opportunities, but supply-chain issues, changes in contract award timing, and intensifying competition have significantly weakened near-term revenue and earnings expectations. It therefore maintains its Neutral rating and halves its price target.

Core views

York Space Systems' 2Q26 revenue was $92.5 million, up 10% year over year, primarily driven by revenue contributed by acquisitions completed over the past 12 months and a new commercial contract. Revenue was 4% above both FactSet market consensus and Goldman Sachs' forecast, indicating that quarterly revenue was slightly better than expected; however, profitability and cash flow were clearly weak. Adjusted EBITDA was negative $9.5 million, below the negative $1.5 million market consensus and also below Goldman Sachs' forecast. Quarterly free cash flow was negative $103.5 million, widening significantly from negative $20.5 million in the prior-year period, indicating that revenue growth has yet to translate into profitability and cash-generation capacity. Orders and the balance sheet present a combination of opportunities and pressures. Quarter-end backlog was $592 million, down from $642 million in the previous quarter. The company held $534 million in cash, equivalent to $4.17 per share, but the report also listed net debt/adjusted EBITDA at 21.9x. Goldman Sachs believes the company's backlog of defense programs remains substantial and its commercial program pipeline is growing, but the decline in backlog, sizable quarterly cash outflow, and negative EBITDA indicate that program conversion, execution, and working capital remain important constraints. The most critical change in this earnings report was the company's reduction of its 2026 revenue guidance to $375 million—$405 million, well below the previous $545 million—$595 million range and the $558 million market consensus; based on the guidance midpoint, this represents a 32% cut. The company attributed the revision to supply-chain constraints and a reassessment of contract award timing. This implies that some program revenue originally expected to be recognized in 2026 may be delayed, while supply-chain issues are also limiting the pace at which existing orders convert into revenue. The competitive environment further reduces visibility into the conversion of the program pipeline into firm revenue. Goldman Sachs notes that although defense demand is substantial and commercial opportunities continue to increase, contract awards in the company's niche are distributed among multiple companies, and the space industry also includes larger, competitive rivals. Therefore, a sizable pipeline of potential programs does not itself guarantee that York will secure contracts, deliver products, and recognize revenue on its original timetable, which is an important reason for Goldman Sachs' Neutral view. Following changes to guidance and its competitive assessment, Goldman Sachs lowered its 2026—2030 revenue forecasts from $548 million, $810 million, $1.003 billion, $1.223 billion, and $1.468 billion to $398 million, $549 million, $680 million, $830 million, and $930 million, respectively. The model also forecasts EBITDA of negative $52.3 million, negative $27.6 million, and positive $49.2 million for 2026—2028, respectively, indicating that the timing of reaching profitability has been delayed. EPS forecasts for the same period are negative $1.93, negative $0.56, and negative $0.12, compared with previous forecasts of negative $0.91, positive $0.40, and positive $0.73, respectively. Goldman Sachs expects gross margin to increase from 21.1% in 2026 to 24.7% in 2027 and 32.0% in 2028, but EBIT margins over the same period remain negative 54.8%, negative 15.4%, and negative 1.6%, respectively, reflecting that improvements in revenue scale and gross margin remain insufficient to generate stable operating profit within the forecast period. On valuation, Goldman Sachs lowered its 12-month price target from $28 to $14. The new price target applies a 2.4x EV/Sales multiple to expected calendar-year 2028 revenue, down from the previous 3.4x multiple; the multiple reduction reflects a reassessment of satellite contract awards and market revaluation of comparable companies. The simultaneous reductions in revenue forecasts and the valuation multiple halved the price target. Nevertheless, Goldman Sachs did not shift to a negative rating and continues to assign a Neutral rating based on the remaining defense and commercial program opportunities.

Analysis framework

Goldman Sachs first compares quarterly revenue, adjusted EBITDA, and free cash flow with its own forecasts, FactSet consensus, and the prior-year period; it then examines backlog, cash, and leverage and analyzes the impact of supply constraints and contract award timing on revenue recognition. The firm subsequently combines the defense and commercial program pipelines with the competitive landscape to reassess annual revenue, margins, and EPS, and finally derives a 12-month price target using an EV/Sales multiple on expected 2028 revenue.

Methodology notes

• Valuation Methodology

  CY28E EV/Sales multiple valuation

  Goldman Sachs calculates the price target using a multiple of enterprise value to expected calendar-year 2028 revenue. The report applies 2.4x, down from 3.4x previously, to reflect changes in the outlook for satellite contract awards and market revaluation of comparable companies.

• Event-Driven Strategy and Behavioral Finance

  Goldman Sachs M&A rating framework

  This framework combines qualitative and quantitative factors to classify potential acquisition probability into Levels 1 through 3. York's M&A rating is 3, corresponding to a low probability of 0%—15%; therefore, M&A considerations are deemed immaterial and are not incorporated into the price target.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• York Space Systems (YSS)

  The report believes the company benefits from a substantial backlog of defense programs and a growing commercial program pipeline, but supply-chain issues, award timing, and competitive pressures weaken revenue conversion and earnings visibility.

  Strengths

  2Q26 revenue increased 10% year over year and slightly exceeded expectations; the defense program backlog is substantial, the commercial program pipeline continues to grow, and the company held $534 million in cash at quarter-end.

  Weaknesses

  Adjusted EBITDA and free cash flow were negative, backlog declined sequentially, the midpoint of 2026 revenue guidance was cut by 32%, and medium- to long-term revenue and EPS forecasts were sharply reduced.

  Comparison

  Contract awards in its niche are distributed among multiple companies, and it faces larger, competitive rivals in the space industry.

  Risks

  Backlog concentration, deterioration in the competitive landscape, and weaker-than-expected operational execution.

Key data

• 2Q26 revenue$92.5 millionUp 10% year over year and 4% above both FactSet consensus and Goldman Sachs' forecast
• 2Q26 adjusted EBITDANegative $9.5 millionBelow the negative $1.5 million market consensus and also below Goldman Sachs' forecast
• 2Q26 free cash flowNegative $103.5 millionNegative $20.5 million in the prior-year period
• Ending backlog$592 million$642 million in the previous quarter
• Ending cash$534 millionEquivalent to $4.17 per share
• Net debt/adjusted EBITDA21.9xQuarter-end leverage metric disclosed by the company
• 2026 revenue guidance$375 million—$405 millionPreviously $545 million—$595 million, with market consensus at $558 million; guidance midpoint cut by 32%
• 2026—2030 revenue forecasts$398 million/$549 million/$680 million/$830 million/$930 millionPreviously $548 million/$810 million/$1.003 billion/$1.223 billion/$1.468 billion
• 2026—2028 EPS forecastsNegative $1.93/negative $0.56/negative $0.12Previously negative $0.91/positive $0.40/positive $0.73, respectively
• 12-month price target$14Previously $28, based on 2.4x CY28E EV/Sales versus the prior multiple of 3.4x
• M&A rating3Corresponds to a low potential acquisition probability of 0%—15% and is not incorporated into the price target
• Market capitalization and enterprise value$1.3 billion/$942.9 millionMarket capitalization and enterprise value presented in the report

Impact & implications

Goldman Sachs believes the substantial reductions in revenue guidance and multiyear forecasts indicate that the effects of supply-chain constraints and contract award delays on the company's growth trajectory are not limited to a single quarter. The company still has defense and commercial program opportunities, but competition is causing orders to be distributed among multiple companies, reducing the certainty that the program pipeline will convert into revenue. Meanwhile, negative EBITDA and significant cash outflows make execution capability and the timing of reaching profitability increasingly critical. Based on lower revenue forecasts and a lower valuation multiple, Goldman Sachs halves its price target but maintains its Neutral rating, citing the balance between potential demand opportunities and actual execution pressures.

Risks

• Backlog concentration could cause changes in a single program to have a significant impact on revenue and cash flow.
• Intensifying competition could reduce the company's share of contract awards and compress the program pipeline conversion rate.
• Weaker-than-expected operational execution could further delay deliveries, revenue recognition, and profitability improvement.